NCT00843284View on ClinicalTrials.gov

Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA

CompletedOBSERVATIONAL
Enrollment

691

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Neuropathic Pain
Interventions
DRUG

Pregabalin

Capsules, 150 - 600 mg/day, 2-3 times/day, 8 weeks

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00843284 - Symptomatic Treatment Of Patients With Neuropathic Pain With LYRICA | Biotech Hunter | Biotech Hunter